Brief: Sunesis Pharma - Nasdaq Granted Co A Second 180 Day Compliance Period To Demonstrate Compliance

Viracta Therapeutics

07/01/2020 22:33

Jan 7 (Reuters) - Sunesis Pharmaceuticals Inc  SNSS.O :
    * SUNESIS PHARMACEUTICALS - NASDAQ GRANTED CO A SECOND 180
DAY
COMPLIANCE PERIOD TO DEMONSTRATE COMPLIANCE

Source: (https://bit.ly/2T8B5gK)
Further company coverage:  SNSS.O 

 ((Reuters.Briefs@thomsonreuters.com;))